Aroul Ramadass, Author at Oxford BioDynamics

OBD to present EpiSwitch® CiRT Clinical Utility Data at ASCO 2022

by Aroul Ramadass

Annual Report 2021 Published

Annual Report 2021

by Aroul Ramadass

Checkpoint Inhibitor Response Test (EpiSwitch® CiRT) for oncology launched in US

by Aroul Ramadass

Genomic Architecture Differences at the HTT Locus Associated with Symptomatic and Pre-Symptomatic Cases of Huntington’s Disease in a Pilot Study

Psychiatry Open Access

by Aroul Ramadass

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.

J Transl Med 19, 46 (2021)

by Aroul Ramadass

A conversation about Systemic Sclerosis

EBR, Autumn 2020

by Aroul Ramadass

The Prospective Study of Epigenetic Regulatory Profiles in Sport and Exercise Monitored Through Chromosome Conformation Signatures

Genes 2020, 11(8), 905

by Aroul Ramadass

Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies

Translational Medicine Communications volume 5, Article number: 5 (2020)

by Aroul Ramadass

EpiSwitch® used in diagnosis of canine lymphoma

by Aroul Ramadass

Ectopic gene deregulations and chromosome conformations: integrating novel molecular testing into clinical applications, from leukemias to gliomas

Handbook of Biomarkers and Precision Medicine, 1st Edition

by Aroul Ramadass